Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.76 |
| ▸ | RAB9A | P51151 | 5/20 | 0.76 |
| ▸ | NPC1 | O15118 | 4/20 | 0.76 |
| ▸ | TP53 | P04637 | 4/20 | 0.76 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.76 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.76 |
| ▸ | RELA | Q04206 | 1/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.69 |
| ▸ | MEN1 | O00255 | 4/20 | 0.69 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.69 |
| ▸ | GPR17 | Q13304 | 1/20 | 0.68 |
| ▸ | KCNK3 | O14649 | 7/20 | 0.66 |
| ▸ | KCNK9 | Q9NPC2 | 3/20 | 0.64 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11710023 | 0.90 | RAB9A (0.76) | SMN1; SMN2RAB9ANPC1TP53NFKB1 | |
| SCHEMBL259706 | 0.87 | MEN1 (0.77) | SMN1; SMN2RAB9ANPC1TP53NFKB1 | |
| SCHEMBL4610855 | 0.86 | MEN1 (0.72) | SMN1; SMN2RAB9ANPC1TP53NFKB1 | |
| SCHEMBL259430 | 0.86 | NPC1 (1.00) | SMN1; SMN2RAB9ANPC1TP53NFKB1 | |
| SCHEMBL14363224 | 0.84 | MEN1 (0.73) | SMN1; SMN2RAB9ANPC1TP53NFKB1 | |
| SCHEMBL8461683 | 0.84 | MEN1 (0.73) | SMN1; SMN2RAB9ANPC1TP53NFKB1 | |
| SCHEMBL29434800 | 0.83 | KCNK3 (0.87) | SMN1; SMN2RAB9ANPC1TP53NFKB1 | |
| SCHEMBL259468 | 0.83 | KCNK3 (0.87) | SMN1; SMN2RAB9ANPC1TP53NFKB1 | |
| SCHEMBL2908619 | 0.83 | MEN1 (0.89) | SMN1; SMN2RAB9ANPC1TP53NFKB1 | |
| SCHEMBL23070479 | 0.83 | RAB9A (0.80) | SMN1; SMN2RAB9ANPC1TP53KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3757179-A1 | INK COMPOSITION FOR INKJET PRINTING, IMAGE FORMING METHOD, AND RECORDED MATERIAL | Fujifilm Corporation (JP) | 2020-12-30 | — | — | EP | disclosed |
| US-20200347252-A1 | INK COMPOSITION FOR INK JET PRINTING, IMAGE FORMING METHOD, AND RECORDED MATERIAL | FUJIFILM CORPORATION (JP) | 2020-11-05 | — | — | US | disclosed |
| EP-3502198-A1 | INK FOR INK JET RECORDING, INK JET RECORDING METHOD, INFRARED READING METHOD, AND PRINTED PRODUCT | FUJIFILM Corporation (JP) | 2019-06-26 | — | — | EP | disclosed |
| EP-1660437-B1 | HYDROXAMIC ACID DERIVATIVES AND THE METHOD FOR PREPARING THEREOF | AMOREPACIFIC CORP (KR) | 2008-10-15 | — | — | EP | disclosed |
| US-7282522-B2 | Hydroxamic acid derivatives and the method for preparing thereof | AMOREPACIFIC CORPORATION (KR) | 2007-10-16 | — | — | US | disclosed |
| US-20060252834-A1 | Hydroxamic acid derivatives and the method for preparing thereof | AMOREPACIFIC CORPORATION (KR) | 2006-11-09 | — | — | US | disclosed |
| EP-1660437-A4 | HYDROXAMIC ACID DERIVATIVES AND THE METHOD FOR PREPARING THEREOF | AMOREPACIFIC CORP (KR) | 2006-09-20 | — | — | EP | disclosed |
| EP-1660437-A1 | HYDROXAMIC ACID DERIVATIVES AND THE METHOD FOR PREPARING THEREOF | Amorepacific Corporation (KR) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005019162-A1 | HYDROXAMIC ACID DERIVATIVES AND THE METHOD FOR PREPARING THEREOF | AMOREPACIFIC CORPORATION (KR) | 2005-03-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060252834-A1 | Hydroxamic acid derivatives and the method for preparing thereof | HDAC7, SIRT7, HCAR1 | SMN1; SMN2 2940/4885RAB9A 4487/4885NPC1 2347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.